Opendata, web and dolomites

LymphoDrain SIGNED

First subcutaneous implant to treat lymphedema. Definitive solution for chronic lymphedema

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LymphoDrain project word cloud

Explore the words cloud of the LymphoDrain project. It provides you a very rough idea of what is the project "LymphoDrain" about.

cover    2016    treatment    people    laboratory    university    15    positions    plan    accelerator    models    unstoppable    created    draining    disorders    competition    2017    business    finalist    awards    grant    medtech    treatments    swiss    million    dr    successfully    lymphatica    pisano    prof    hospital    cti    patented    switzerland    presently    spin    initial    uses    attracting    vision    termis    population    consciously    financial    pump    lausanne    replace    implantable    innovation    off    magnetically    function    lymphatic    treat    moment    catheters    coupled    lymphodrain    national    triacca    received    top3    care    company    health    tested    team    clinical    vessel    venture    stage    melody    recognition    chronic    qualified    micro    suffer    underlying    trajectory    kick    led    segment    lack    animal    valentina    situation    fit    ait    invention    multidisciplinary    perspective    participated    disruptive    epfl    designed    winner    swartz    federal    imagine    cancer    masschallenge    lymphedema    market    bioengineering    marco    chuv    international   

Project "LymphoDrain" data sheet

The following table provides information about the project.

Coordinator
LYMPHATICA MEDTECH SA 

Organization address
address: BATIMENT E EPFL INNOVATION PARK
city: LAUSANNE
postcode: 1015
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://www.lymphatica.ch
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LYMPHATICA MEDTECH SA CH (LAUSANNE) coordinator 50˙000.00

Map

 Project objective

Lymphatica Medtech S.A. is a spin-off company created in 2017, from the Swiss Federal Institute of Technology in Lausanne (EPFL) and the Lausanne University Hospital (CHUV). It has designed and patented “LymphoDrain” a novel implantable system to replace the lymphatic vessel draining function to treat lymphatic disorders, in particular chronic lymphedema. It uses an underlying technology based on a magnetically controlled micro-pump coupled with draining catheters. LymphoDrain was developed by Dr. Marco Pisano and Dr. Valentina Triacca, in the Laboratory of Lymphatic and Cancer Bioengineering led by Prof. Melody Swartz. Since the initial invention, a multidisciplinary and highly qualified team has participated in the project bringing clinical perspective and attracting financial support from several organizations (CTI grant, FIT grant, AIT innovation grant). The recognition has been received at both national (Winner of Venture Kick stage I and II, Top3 at Venture Business Plan Competition 2016) and international level (finalist at Imagine IF Accelerator 2016, Top 2 at TERMIS-EU Business Plan Competition 2016). At the moment, Lymphatica is a finalist in the MassChallenge Switzerland Awards 2017 on a trajectory of unstoppable growth and recognition. LymphoDrain technology was consciously designed as an implantable system to cover the needs of a segment of the population, estimated at more than 15 million people in Europe and US who suffer of chronic lymphedema and presently lack effective treatments. The functionality of LymphoDrain has been successfully tested in large animal models. This vision positions LymphoDrain in a unique situation to access both the European and the US health care market as a disruptive technology in the treatment of lymphedema.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYMPHODRAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LYMPHODRAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

scanvid (2017)

ScanVid - One-Click Integrated Access to Product-related Digital Content

Read More  

BioAhead (2017)

BioAhead – an innovative optimization algorithm for amino acid chain analytics

Read More